Characterization of traumatic brain injury in human brains reveals distinct cellular and molecular changes in contusion and pericontusion G Harish, A Mahadevan, N Pruthi, SK Sreenivasamurthy, ... Journal of neurochemistry 134 (1), 156-172, 2015 | 95 | 2015 |
Phosphoproteome of Cryptococcus neoformans LDN Selvan, S Renuse, JE Kaviyil, J Sharma, SM Pinto, SD Yelamanchi, ... Journal of proteomics 97, 287-295, 2014 | 68* | 2014 |
Molecular and clinical studies in 107 Noonan syndrome affected individuals with PTPN11 mutations JP Athota, M Bhat, S Nampoothiri, K Gowrishankar, SG Narayanachar, ... BMC medical genetics 21, 1-10, 2020 | 67 | 2020 |
Identification of differentially expressed serum proteins in gastric adenocarcinoma Y Subbannayya, SA Mir, S Renuse, SS Manda, SM Pinto, ... Journal of proteomics 127, 80-88, 2015 | 64 | 2015 |
A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma A Radhakrishnan, V Nanjappa, R Raja, G Sathe, VN Puttamallesh, ... Scientific reports 6 (1), 36132, 2016 | 55 | 2016 |
Proteomic analysis of purified protein derivative of Mycobacterium tuberculosis TSK Prasad, R Verma, S Kumar, RS Nirujogi, GJ Sathe, AK Madugundu, ... Clinical proteomics 10, 1-9, 2013 | 40 | 2013 |
Chronic exposure to cigarette smoke leads to activation of p21 (RAC1)-activated kinase 6 (PAK6) in non-small cell lung cancer cells R Raja, NA Sahasrabuddhe, A Radhakrishnan, N Syed, HS Solanki, ... Oncotarget 7 (38), 61229, 2016 | 37 | 2016 |
Proteomic profiling of serum samples from chikungunya-infected patients provides insights into host response VN Puttamallesh, SK Sreenivasamurthy, PK Singh, HC Harsha, ... Clinical proteomics 10, 1-11, 2013 | 32 | 2013 |
Host response profile of human brain proteome in toxoplasma encephalitis co-infected with HIV A Sahu, S Kumar, SK Sreenivasamurthy, LDN Selvan, AK Madugundu, ... Clinical proteomics 11, 1-13, 2014 | 26 | 2014 |
Cigarette smoke induces mitochondrial metabolic reprogramming in lung cells HS Solanki, N Babu, AP Jain, MY Bhat, VN Puttamallesh, J Advani, ... Mitochondrion 40, 58-70, 2018 | 24 | 2018 |
Phosphoproteomic profiling identifies aberrant activation of integrin signaling in aggressive non-type bladder carcinoma B Deb, VN Puttamallesh, K Gondkar, JP Thiery, H Gowda, P Kumar Journal of clinical medicine 8 (5), 703, 2019 | 18 | 2019 |
Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor HS Solanki, R Raja, A Zhavoronkov, IV Ozerov, AV Artemov, J Advani, ... Oncoscience 5 (1-2), 21, 2018 | 17 | 2018 |
Seroprevalence of Lymes disease in the Nagarahole and Bandipur forest areas of South India K Babu, KR Murthy, M Bhagya, PR Murthy, VN Puttamallesh, V Ravi Indian Journal of Ophthalmology 68 (1), 100-103, 2020 | 16 | 2020 |
Quantitative proteomics of urinary bladder cancer cell lines identify UAP1 as a potential therapeutic target VN Puttamallesh, B Deb, K Gondkar, A Jain, B Nair, A Pandey, ... Genes 11 (7), 763, 2020 | 15 | 2020 |
Phosphoproteomics of retinoblastoma: a pilot study identifies aberrant kinases LDN Selvan, R Danda, AK Madugundu, VN Puttamallesh, GJ Sathe, ... Molecules 23 (6), 1454, 2018 | 12 | 2018 |
Molecular alterations in oral cancer using high-throughput proteomic analysis of formalin-fixed paraffin-embedded tissue V Mohanty, Y Subbannayya, S Patil, VN Puttamallesh, MA Najar, KK Datta, ... Journal of cell communication and signaling 15, 447-459, 2021 | 8 | 2021 |
An integrated approach for identification of a panel of candidate genes arbitrated for invasion and metastasis in oral squamous cell carcinoma S Routray, R Kumar, KK Datta, VN Puttamallesh, A Chatterjee, H Gowda, ... Scientific Reports 11 (1), 6208, 2021 | 6 | 2021 |
Identification of spleen tyrosine kinase as a potential therapeutic target for esophageal squamous cell carcinoma using reverse phase protein arrays MA Barbhuiya, MK Kashyap, VN Puttamallesh, RV Kumar, X Wu, ... Oncotarget 9 (26), 18422, 2018 | 5 | 2018 |
Correction: Corrigendum: A dual specificity kinase, DYRK1A, as a potential therapeutic target for head and neck squamous cell carcinoma A Radhakrishnan, V Nanjappa, R Raja, G Sathe, VN Puttamallesh, ... Scientific reports 7 (1), 46864, 2017 | 3 | 2017 |
Correction: Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor HS Solanki, R Raja, A Zhavoronkov, IV Ozerov, AV Artemov, J Advani, ... Oncoscience 8, 108, 2021 | 2 | 2021 |